These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat. Schipper T; Van Poucke M; Sonck L; Smets P; Ducatelle R; Broeckx BJG; Peelman LJ Eur J Hum Genet; 2019 Nov; 27(11):1724-1730. PubMed ID: 31164718 [TBL] [Abstract][Full Text] [Related]
3. Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy. O'Donnell K; Adin D; Atkins CE; DeFrancesco T; Keene BW; Tou S; Meurs KM Anim Genet; 2021 Aug; 52(4):542-544. PubMed ID: 33970514 [TBL] [Abstract][Full Text] [Related]
5. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316 [TBL] [Abstract][Full Text] [Related]
7. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy. Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV; Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366 [TBL] [Abstract][Full Text] [Related]
8. The genetic basis of hypertrophic cardiomyopathy in cats and humans. Kittleson MD; Meurs KM; Harris SP J Vet Cardiol; 2015 Dec; 17 Suppl 1(Suppl 1):S53-73. PubMed ID: 26776594 [TBL] [Abstract][Full Text] [Related]
9. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]
10. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy. Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161 [TBL] [Abstract][Full Text] [Related]
11. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy. Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319 [TBL] [Abstract][Full Text] [Related]
12. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients. Jaafar N; Gómez J; Kammoun I; Zairi I; Amara WB; Kachboura S; Kraiem S; Hammami M; Iglesias S; Alonso B; Coto E Genet Test Mol Biomarkers; 2016 Nov; 20(11):674-679. PubMed ID: 27574918 [TBL] [Abstract][Full Text] [Related]
13. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. Roncarati R; Latronico MV; Musumeci B; Aurino S; Torella A; Bang ML; Jotti GS; Puca AA; Volpe M; Nigro V; Autore C; Condorelli G J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287 [TBL] [Abstract][Full Text] [Related]
15. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction. Kinnear C; Said A; Meng G; Zhao Y; Wang EY; Rafatian N; Parmar N; Wei W; Billia F; Simmons CA; Radisic M; Ellis J; Mital S Cell Rep Med; 2024 May; 5(5):101520. PubMed ID: 38642550 [TBL] [Abstract][Full Text] [Related]
16. Precision medicine validation: identifying the Ontiveros ES; Ueda Y; Harris SP; Stern JA; J Feline Med Surg; 2019 Dec; 21(12):1086-1093. PubMed ID: 30558461 [TBL] [Abstract][Full Text] [Related]
17. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ; Maron MS; Semsarian C J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258 [TBL] [Abstract][Full Text] [Related]
18. Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy. Meurs KM; Norgard MM; Kuan M; Haggstrom J; Kittleson M J Vet Intern Med; 2009; 23(4):840-3. PubMed ID: 19566849 [TBL] [Abstract][Full Text] [Related]
19. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277 [TBL] [Abstract][Full Text] [Related]
20. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Meurs KM; Sanchez X; David RM; Bowles NE; Towbin JA; Reiser PJ; Kittleson JA; Munro MJ; Dryburgh K; Macdonald KA; Kittleson MD Hum Mol Genet; 2005 Dec; 14(23):3587-93. PubMed ID: 16236761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]